Duke Cancer Institute Cary is a clinical research site located in Cary, North Carolina, United States 27518.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Duke Cancer Institute Cary has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: Prostate Cancer, Gastric Neuroendocrine Carcinoma, Intestinal Neuroendocrine Carcinoma.
Sponsors: Duke University, ECOG-ACRIN Cancer Research Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Cary
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Cancer Institute Cary has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Cancer Institute Cary has 5 clinical trials on record, with 4 currently active. Their work covers Prostate Cancer, Gastric Neuroendocrine Carcinoma, Intestinal Neuroendocrine Carcinoma.
Duke Cancer Institute Cary has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.